Jing S, Liping Y, "Clinical observation on late stage lung cancer treating with chemotherapy and compound kushen injection", Traditional Chinese medicine in Inner Mongolia, vol. 11, pp. 13-14, 2012.Jing S., Liping Y. Clinical observation on late stage lung cancer treating with chemotherapy ...
Blood stream cancers being one of the most difficult cancer types to treat, allogeneic stem cell transplantation with chemotherapy or radiotherapy was the conventional treatment process over the decades. Since most of hematologic malignancies caused by precursor B or T cells, T cell therapy using ...
2,3 The current standard of care for patients with GBM consists of maximal surgical resection followed by radiotherapy and chemotherapy with temozolomide (TMZ). However, even with this combination of treatment, the median overall survival (OS) is around 10–16 months, with fewer than 10% of ...
To retrospectively review the safety and clinical efficacy of bevacizumab concomitant with chemotherapy in Chinese patients with advanced non-squamous non-small cell lung cancer (NSNSCLC).Clinical data for 79 patients with NSNSCLC who received bevacizumab concomitant with chemotherapy in Chinese PLA Genera...
et al. Targeted radiosensitization with PARP1 inhibition: optimization of therapy and identification of biomarkers of response in breast cancer. Breast Cancer Res. Treat. 147, 81–94 (2014). Article CAS PubMed Google Scholar O'Shaughnessy, J. et al. Iniparib plus chemotherapy in metastatic tr...
2 However, at the time of diagnosis, over 75% of lung cancer patients present are unsuitable for surgery due to their advanced or metastatic diseases.3,4 In the last decades, multiple novel therapy strategies for lung cancers have been introduced, including platinum-based double chemotherapy, ...
Alternatives to prostate cancer surgery include radiotherapy, chemotherapy, the use of hormonal or immune agents, brachytherapy and HIFU ablation of the prostate. These methods can be used either alone or in conjunction with surgery. Careful diagnosis and a multidisciplinary approach to treatment are ne...
In this trial, an immunotherapy drug called pembrolizumab (KEYTRUDA), used in conjunction with neoadjuvant chemotherapy (i.e., given before surgery) and then again after surgery, has been shown to slowcancerprogression and recurrence and to reduce the presence of residual tumors in patients with e...
In the past, the prognosis for those with unresectable, locally advanced non-small cell lung cancer has been poor, with low survival rates despite treatment with a combination of chemotherapy and radiation. Current standard of care for this group of patients consists of 30 treatments spanning over...
19.The method of any one of claims 1-17, wherein the cancer is breast cancer. 20.The method of any one of claims 1-17, wherein the cancer is colon cancer. 21.The method of any one of claims 1-17, wherein the cancer is lung cancer. ...